South Korea Single Cell Sequencing Market (2025-2030)
The South Korea Single Cell Sequencing Market was valued at $20 Million in 2025 and projected to reach to $29.6 Million by 2030, representing a compound annual growth rate of 8.2%. South Korea's single cell sequencing market is poised for steady expansion driven by robust government support for genomic research initiatives and increasing collaboration between academic institutions and biotech companies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea Single Cell Sequencing Market Trends and Insights
- South Korea's advanced biotechnology infrastructure and strong investment in genomic research are driving adoption of single cell sequencing technologies across academic and clinical institutions.
- South Korea's position as a leader in life sciences innovation supports the expansion of precision medicine applications and cellular research initiatives. The South Korea market benefits from increasing government funding for genomic research and a growing number of research collaborations between universities and pharmaceutical companies.
- South Korea's healthcare system's emphasis on cutting-edge diagnostic and therapeutic development creates favorable conditions for single cell sequencing adoption.
- Between 2025 and 2030, South Korea is expected to see accelerated integration of these technologies in cancer research, immunology, and regenerative medicine applications..
Key Market Statistics
- CAGR (2025-2030) 8.2% CAGR
- Market Size, 2025 ~USD 20 Million
- Forecast, 2030 ~USD 29.6 Million
- Country South Korea
South Korea Single Cell Sequencing Market Overview
Market Valuation Growth :
South Korea's single cell sequencing market is valued at $20.0 million in 2025, with a projected CAGR of 8.2% through 2030, reaching $29.6 million by forecast end.
Biotechnology Infrastructure :
South Korea maintains advanced biotechnology infrastructure with significant government and private sector investment in genomic research facilities and innovation hubs across Seoul, Daejeon, and Busan.
Academic and Clinical Adoption :
Leading South Korean universities and medical institutions are rapidly adopting single cell sequencing technologies for cancer research, immunology studies, and personalized medicine applications.
Life Science Leadership :
South Korea's position as a regional life science leader is strengthened by competitive advantages in precision medicine, biopharmaceutical development, and genomic research capabilities.
South Korea Single Cell Sequencing Market Dynamics
- The country's emphasis on precision medicine and personalized healthcare solutions is accelerating technology adoption across research centers and clinical laboratories.
- Investment in next-generation sequencing infrastructure and skilled workforce development will further propel market growth.
- South Korea's strategic focus on becoming a global biotech hub, combined with rising demand for advanced diagnostic tools in oncology and immunotherapy research, positions the market for sustained development through 2030..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- South Korea's single cell sequencing market is valued at $20.0 million in 2025 with a projected CAGR of 8.2% through 2030.
- South Korea's advanced research infrastructure and government genomic funding initiatives are primary growth catalysts for market expansion.
- South Korea's market is expected to reach $29.6 million by 2030, driven by increased adoption in precision medicine and cellular research.
- South Korea's pharmaceutical and biotech sectors are increasingly integrating single cell sequencing for drug discovery and development applications.
Single Cell Sequencing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 12.2% from 2025 to 2030 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 1.95 (2025) |
| Revenue Forecast (Billions) | ~USD 3.46 (2030) |
| Segments Covered | Offering, Type, End User, Sequencing Type, Application, Workflow |
South Korea Single Cell Sequencing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Basic & Translational Research
- Cancer Research
- Cell Sorters
- Consumables
- Data Analysis & Bioinformatics Services
- Data Storage & Management Software
- Drug Discovery & Development
- Instruments
- Lcm Instruments
- Library Preparation Services
- Microbiology & Infectious Diseases
- Microfluidic Instruments
- Neurology & Brain Research
- Organ Development & Regenerative Medicine
- Other Pre-Sequencing Instruments
- Pcr Instruments
- Pre-Sequencing Instruments
- Pre-Sequencing Reagents & Kits
- Pre-Sequencing Services
- Sample Preparation, Single-Cell Isolation, And Enrichment Services
- Sequencing Platforms
- Sequencing Reagents & Kits
- Sequencing Services
- Software
- Software Tools
- Stem Cell & Developmental Biology
By End User
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Cros
- Hospitals & Clinical Laboratories
- Pharmaceutical & Biopharmaceutical Companies
By Sequencing Type
- Other Single-Cell Sequencing Types
- Scatac-Seq
- Scdna-Seq
- Scrna-Seq
By Application
- Diagnostic & Clinical Applications
- Research Applications
By Workflow
- Data Analysis & Interpretation
- Pre-Sequencing
- Sequencing
Target Audience
- Biotech Companies : South Korea-focused biotech firms need market sizing and growth projections to plan product launches, allocate R&D resources, and identify partnership opportunities with local research institutions.
- Medical Device Manufacturers : Equipment and sequencing platform providers require South Korea-specific market data to assess demand, competitive positioning, and revenue potential in this advanced life science market.
- Research Institutions : Academic centers and research hospitals in South Korea need market intelligence to justify technology investments, secure funding, and benchmark their genomic research capabilities regionally.
- Investment Firms : Venture capital and private equity investors targeting South Korea's biotech sector require detailed market analysis to evaluate investment opportunities and portfolio company growth potential.
- Healthcare Consultants : Management consulting firms advising South Korean healthcare organizations need country-specific market data to develop precision medicine strategies and technology adoption roadmaps.
Reasons to Buy this Report
- Market-Specific Sizing Data : Access precise valuation figures for South Korea's single cell sequencing market with country-specific CAGR (8.2%) and 5-year forecast projections essential for regional business planning.
- Competitive Landscape Intelligence : Understand South Korea's unique biotechnology ecosystem, institutional adoption patterns, and competitive positioning relative to regional and global markets for strategic market entry.
- Investment Decision Support : Leverage detailed South Korea market analysis to identify growth opportunities, assess market maturity, and make informed investment decisions in the country's genomic research sector.
- Regulatory and Infrastructure Insights : Gain understanding of South Korea's advanced biotech infrastructure, government support mechanisms, and institutional frameworks that influence single cell sequencing technology adoption.
- Regional Expansion Strategy : Develop targeted go-to-market strategies for South Korea by understanding local academic institutions, clinical centers, and research organizations driving technology adoption and market growth.
Frequently asked questions
What is the current market size of single cell sequencing in South Korea?
South Korea's single cell sequencing market is valued at $20.0 million in 2025.
What is the projected market size for single cell sequencing in South Korea by 2030?
South Korea's single cell sequencing market is projected to reach $29.6 million by 2030.
What is the CAGR for South Korea's single cell sequencing market?
South Korea's single cell sequencing market is expected to grow at a CAGR of 8.2% from 2025 to 2030.
What factors are driving growth in South Korea's single cell sequencing market?
South Korea's market growth is driven by advanced biotechnology infrastructure, government genomic research funding, and increasing adoption in precision medicine and cancer research applications.
Which sectors in South Korea are adopting single cell sequencing technology?
South Korea's pharmaceutical companies, biotech firms, academic research institutions, and clinical centers are increasingly adopting single cell sequencing for drug discovery, immunology, and regenerative medicine research.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Single Cell Sequencing Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).
Stakeholders
- Academic & Research Institutes
- Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
- Contract Research Organizations (CROs)
- Single-cell Sequencing Service & Software Providers
- Diagnostics Companies
- Market Research & Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government organizations
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals and Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
- To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
- Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
- Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
- Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the other technologies into subsegments
- Cross-segment analysis
Get the Full Single Cell Sequencing Market Report
Full forecast, segment splits, and company analysis for all Single Cell Sequencing Market.
- US Single Cell Sequencing Market
- Canada Single Cell Sequencing Market
- UK Single Cell Sequencing Market
- Germany Single Cell Sequencing Market
- France Single Cell Sequencing Market
- Italy Single Cell Sequencing Market
- Spain Single Cell Sequencing Market
- China Single Cell Sequencing Market
- Japan Single Cell Sequencing Market
- India Single Cell Sequencing Market
- Australia Single Cell Sequencing Market
- Brazil Single Cell Sequencing Market
- Mexico Single Cell Sequencing Market
- Rest Of Europe Single Cell Sequencing Market
- Rest Of Asia Pacific Single Cell Sequencing Market
- Rest Of Latin America Single Cell Sequencing Market
- Ksa Single Cell Sequencing Market
- Other GCC Countries Single Cell Sequencing Market
- UAE Single Cell Sequencing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
